09/24/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/24/2020. This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Xpert Xpress SARS-CoV-2/Flu/RSV test. The Xpert Xpress SARS-CoV-2/Flu/RSV test is authorized for use with certain respiratory specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. (PDF)
.png)
No hay comentarios:
Publicar un comentario